Key highlights of the Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025)
- PMID: 40877471
- DOI: 10.1038/s41440-025-02331-8
Key highlights of the Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025)
Abstract
Japan has long maintained a robust national health system with universal health coverage and accessible antihypertensive therapy. Nevertheless, population-level blood pressure (BP) control remains suboptimal. To address this public health challenge, the Japanese Society of Hypertension published the Guidelines for the Management of Elevated Blood Pressure and Hypertension 2025 (JSH2025), integrating evidence-based recommendations and practical approaches to improve hypertension care. JSH2025 introduces a dual-format structure comprising clinical question sections developed through systematic reviews and consensus-based narrative chapters. The key updates include universal BP targets of <130/80 mmHg across populations, promotion of home BP monitoring, stratified cardiovascular risk assessment, expanded guidance on digital health and behavioral interventions, and condition-specific management strategies for older adults, women, and cancer survivors. We outline the major updates and innovations in JSH2025 and show their clinical and public health implications.
Keywords: Clinical practice; Elevated blood pressure; Guidelines; Hypertension; Japanese Society of Hypertension.
© 2025. The Author(s), under exclusive licence to The Japanese Society of Hypertension.
Conflict of interest statement
Compliance with ethical standards. Conflict of interest: The Task Force Committee for the JSH2025 was established in accordance with the Guidance on Eligibility Criteria for Participation in Clinical Practice Guideline Development 2023 issued by the Japan Medical Association. The committee members were selected based on the Conflict of Interest (COI) Management Policy for JSH2025. Declarations of COI for all committee members over the past 3 fiscal years (2022–2024) have been disclosed and are publicly available on the website of the Japanese Society of Hypertension. https://www.jpnsh.jp/data/jsh2025/jsh2025_coi.pdf
References
-
- NCD Risk Factor Collaboration (NCD-RisC). Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. Lancet. 2019;394:639–51. - DOI
-
- Japanese Society of Hypertension Guidelines Committee. The Japanese Society of Hypertension Guidelines for the Management of Elevated Blood Pressure and Hypertension 2025 (JSH2025). Tokyo: Life Science Publishing Co., Ltd.; 2025.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
